Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study

BACKGROUND: The protective immunity against omicron following a BNT162b2 Pfizer booster dose among elderly individuals (ie, those aged >65 years) is not well characterised. METHODS: In a community-based, prospective, longitudinal cohort study taking place in France in which 75 residents from thre...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruel, Timothée, Pinaud, Laurie, Tondeur, Laura, Planas, Delphine, Staropoli, Isabelle, Porrot, Françoise, Guivel-Benhassine, Florence, Attia, Mikaël, Pelleau, Stéphane, Woudenberg, Tom, Duru, Cécile, Koffi, Aymar Davy, Castelain, Sandrine, Fernandes-Pellerin, Sandrine, Jolly, Nathalie, De Facci, Louise Perrin, Roux, Emmanuel, Ungeheuer, Marie-Noëlle, Van Der Werf, Sylvie, White, Michael, Schwartz, Olivier, Fontanet, Arnaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307278/
https://www.ncbi.nlm.nih.gov/pubmed/35891947
http://dx.doi.org/10.1016/j.eclinm.2022.101576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307278/
https://www.ncbi.nlm.nih.gov/pubmed/35891947
http://dx.doi.org/10.1016/j.eclinm.2022.101576

Ejemplares similares